Literature DB >> 1268654

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes.

R C Turner, S T McCarthy, R R Holman, E Harris.   

Abstract

Insulin supplements, predominantly as a constant basal fish insulin infusion, were given to patients with mild diabetes to reduce the overnight fasting glucose level to normal. The basal plasma human insulin levels were reduced to subnormal levels by the infusion, and the insulin response to intravenous glucose was enhanced. The beta-cell in diabetes seems to be in a vicious circle in which an impaired insulin response to glucose produces hyperglycaemia, which stresses beta-cell function, making it more inefficient. A constant basal insulin supplement to induce basal normoglycaemia may benefit beta-cell function in diabetes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268654      PMCID: PMC1639832          DOI: 10.1136/bmj.1.6020.1252

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  9 in total

1.  Effects of hyper- and hypoglycemia on beta cell degranulation and glycogen infiltration in normal, subdiabetic and diabetic rats.

Authors:  A M Carpenter; A Lazarow
Journal:  Diabetes       Date:  1967-07       Impact factor: 9.461

2.  Early response of plasma insulin to small doses of intravenous glucose: effect of obesity.

Authors:  R Pelkonen; M R Taskinen; E A Nikkilä
Journal:  J Clin Endocrinol Metab       Date:  1974-09       Impact factor: 5.958

3.  Suppression of insulin release by fish-insulin-induced hypoglycaemia: with reference to the diagnosis of insulinomas.

Authors:  R C Turner; P C Johnson
Journal:  Lancet       Date:  1973-06-30       Impact factor: 79.321

4.  Relationship between intravenous glucose loads, insulin responses and glucose disappearance rate.

Authors:  R L Lerner; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1971-09       Impact factor: 5.958

5.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

Authors:  J D Albano; R P Ekins; G Maritz; R C Turner
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

6.  Effect of bonito insulin on endogenous insulin secretion in dogs.

Authors:  H Sando; Y Kanazawa; T Kuzuya
Journal:  Am J Physiol       Date:  1970-05

7.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes.

Authors:  S W Shen; G M Reaven; J W Farquhar
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

8.  Effect of control of hyperglycemia on plasma insulin responses to various stimuli in newly diagnosed ketosis-prone diabetic patients.

Authors:  E Foucar; J B Field
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

9.  Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.

Authors:  R L Lerner; D Porte
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

  9 in total
  37 in total

Review 1.  Islet beta cell failure in type 2 diabetes.

Authors:  Marc Prentki; Christopher J Nolan
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

2.  Preservation of insulin mRNA levels and insulin secretion in HIT cells by avoidance of chronic exposure to high glucose concentrations.

Authors:  R P Robertson; H J Zhang; K L Pyzdrowski; T F Walseth
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents.

Authors:  M Krempf; T Godeau; S Ranganathan; P Blanchard; P Ritz; B Charbonnel
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Effects of long-term cranberry supplementation on endocrine pancreas in aging rats.

Authors:  Min Zhu; Jingping Hu; Evelyn Perez; Dawn Phillips; Wook Kim; Reza Ghaedian; Joshua K Napora; Sige Zou
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

5.  Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications.

Authors:  I R Sinay; P Arias; M A Schnitman; S A Damilano; M C Faingold; J A Moguilevsky
Journal:  Acta Diabetol Lat       Date:  1988 Oct-Dec

6.  Evidence for a direct action of exogenous insulin on the pancreatic islets of diabetic mice: islet response to insulin pre-incubation.

Authors:  C Gordon; A P Yates; D Davies
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

7.  The effects of energy and carbohydrate restriction in patients with chronic diabetes mellitus.

Authors:  J R Perkins; T E West; P H Sönksen; C Lowy; C Iles
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

Review 8.  Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Authors:  Juris J Meier; Michael A Nauck
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

9.  Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.

Authors:  P V Højberg; M Zander; T Vilsbøll; F K Knop; T Krarup; A Vølund; J J Holst; S Madsbad
Journal:  Diabetologia       Date:  2008-02-22       Impact factor: 10.122

10.  No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.

Authors:  H Flax; D R Matthews; J C Levy; S W Coppack; R C Turner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.